Cleared Traditional

K130469 - LIAISON TSH, LIAISON CONTROL THYROID 1, LIAISON CONTROL THYROID 2, LIAISON CONTROL THYROID 3

K130469 is an FDA 510(k) clearance for LIAISON TSH, manufactured by DiaSorin, Inc.. The device is a Class 2 Chemistry device with product code JLW cleared through the Traditional 510(k) pathway after a 39-day FDA review.

K130469 · DiaSorin, Inc. · Chemistry device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Apr 2013
Decision
39d
Days
Class 2
Risk

K130469 is an FDA 510(k) clearance for the LIAISON TSH, LIAISON CONTROL THYROID 1, LIAISON CONTROL THYROID 2, LIAISON CO.... Classified as Radioimmunoassay, Thyroid-stimulating Hormone (product code JLW), Class II - Special Controls.

Submitted by DiaSorin, Inc. (Stillwater, US). The FDA issued a Cleared decision on April 5, 2013 after a review of 39 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1690 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K130469

510(k) Number K130469 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 25, 2013
Decision Date April 05, 2013
Days to Decision 39 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
49d faster than avg
Panel avg: 88d · This submission: 39d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JLW Device Classification - Class 2, Special Controls

Product Code JLW Radioimmunoassay, Thyroid-stimulating Hormone
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1690
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JLW Radioimmunoassay, Thyroid-stimulating Hormone

All 218
Devices cleared under the same product code (JLW) and FDA review panel - the closest regulatory comparables to K130469.
ADVIA Centaur TSH3-Ultra
K150403 · Siemens Healthcare Diagnostics, Inc. · May 2015
ADVIA CENTAUR TSH
K141999 · Siemens Healthcare Diagnostics, Inc. · Apr 2015
FREND TSH (REAGENT CARTRIDGE)
K131928 · Nanoentek USA, Inc. · Mar 2014
MICT TSH
K110761 · Magnabiosciences, LLC · Mar 2012
FASTPACK TSH IMMUNOASSAY
K101390 · Qualigen, Inc. · Aug 2010
GSP INSTRUMENT AND GSP NEONATAL HTSH KIT
K090846 · Perkinelmer, Inc. · Sep 2009
K130469 · LIAISON TSH, LIAISON CONTROL THYROID 1, LIAISON CONTROL THYROID 2, LIAISON CONTROL THYROID 3
Download PDF FDA Summary DiaSorin, Inc.